Capital One headquarters in McLean, Virginia on February 20, 2024.
Brendan Smialowski | AFP | Getty Images
The Consumer Financial Protection Bureau announced Tuesday that it was suing Capital One for misleading consumers about their savings account interest rates and “cheating” them out of more than $2 billion in interest.
The agency said in a statement Capital One deceived holders of its “360 Savings” account by conflating it with its newer and higher-yield savings account option, the “360 Performance Savings” account. The bank allegedly failed to notify 360 Savings account holders of the newer option and marketed the two products similarly to lead customers to believe they were the same.
However, the interest rates of the two options were substantially different, according to the CFPB. Capital One increased the 360 Performance Savings interest rate from 0.4% in April 2022 to 4.35% in January 2024, while it lowered and then froze the 360 Savings rate at 0.3% between late 2019 to mid-2024, the agency said.
Despite its relatively low interest rate, the CFPB alleged, the 360 Savings account was advertised as a high-interest savings account. The bureau said Capital One aimed to keep 360 Savings users in the dark about the higher-yield option by replacing all references to the account with the similarly named 360 Performance Savings option on its website, excluding account holders from marketing campaigns advertising the higher-yield account and forbidding employees from notifying account holders about the 360 Performance Savings option.
“The CFPB is suing Capital One for cheating families out of billions of dollars on their savings accounts,” said CFPB Director Rohit Chopra in a news release. “Banks should not be baiting people with promises they can’t live up to.”
In a statement, Capital One denied the allegations and said it transparently marketed its 360 Performance Savings account.
“We are deeply disappointed to see the CFPB continue its recent pattern of filing eleventh hour lawsuits ahead of a change in administration. We strongly disagree with their claims and will vigorously defend ourselves in court,” the company said in a statement.
The bank added the 360 Performance Savings product was “marketed widely, including on national television, with the simplest and most transparent terms in the industry.”
French accounting software firm Pennylane has doubled its valuation to 2 billion euros ($2.16 billion) in a new 75 million euro funding round.
Pennylane told CNBC that it raised the fresh funds from a host of venture funds, with Sequoia Capital leading the round and Alphabet’s CapitalG, Meritech and DST Global also participating.
Founded in 2020, Pennylane sells what it calls an “all-in-one” accounting platform that’s used by accountants and other financial professionals.
The platform is primarily targeted toward small to medium-sized firms, offering tools for functions spanning expensing, invoicing, cash flow management and financial forecasting.
“We came in tailoring a product that looks a bit like [Intuit’s] QuickBooks or Xero but adapting it to the needs of continental accountants, starting with France,” Pennylane’s CEO and co-founder Arthur Waller told CNBC.
Pennylane currently serves around 4,500 accounting firms and more than 350,000 small and medium-sized enterprises. The startup was previously valued at 1 billion euros in a 2024 investment round.
Bitcoin fell below the $79,000 level as investors braced for more financial market volatility after U.S. equites suffered their worst decline since 2020 on the rollout of President Donald Trump’s restrictive global tariffs.
The price of bitcoin was last lower by 4% at $78,835.07, according to Coin Metrics, after trading above the $80,000 for most of this year — barring a couple brief blips below it amid recent volatility. It’s off its January all-time high by about 34%.
Although the flagship cryptocurrency usually trades like a big tech stock and is often viewed by traders as a leading indicator of market sentiment, it bucked the broader market meltdown last week – holding in the $80,000 to $90,000 range and rising to end the week as stocks tumbled and even gold fell.
Other cryptocurrencies suffered bigger losses overnight. Ether and the token tied to Solana tumbled 9% each.
Bitcoin’s down move triggered a wave of long liquidations, as traders betting on an increase in its price were forced to sell their assets to cover their losses. In the past 24 hours, bitcoin has seen more than $181 million in long liquidations, according to CoinGlass. Ether saw $188 million in long liquidations in the same period.
Bitcoin has traded mostly above $80,000 in 2025
Rattled investors dumped their holdings of cryptocurrencies, which trade 24 hours, over the weekend as they anticipated further carnage, after Trump’s retaliatory tariffs raised global recession fears and caused investors to sell all risk.
The duties on all imports, in addition to custom tariffs for major trading partners, have sparked worries of a global trade war that could lead the U.S. into a recession. Growing concerns about the far-reaching impact of the tariffs sent markets reeling worldwide.
In the two sessions following the tariff announcement, global stocks wiped out $7.46 trillion in market value based on the market cap of the S&P Global Broad Market Index, according to S&P Dow Jones Indices.
That figure includes $5.87 trillion lost in the U.S. stock market over those two sessions and another $1.59 trillion loss in market value in other major global markets.
Bitcoin is down 15% in 2025 and, absent a crypto-specific catalyst, is expected to continue moving in tandem with equities as global recession fears overshadow any regulatory tailwinds crypto was expected to benefit from this year.
Worries about tariffs may have rattled global investors, but analysts still expect China’s technology sector to keep riding this year’s wave of interest in homegrown generative artificial intelligence. The latest salvo of U.S. tariffs on China and its Southeast Asia trading partners sent Chinese stocks tumbling at the open Thursday, but they closed well off their lows. Local markets were closed Friday for a holiday. “Many of the larger tech names (and most of the consumer names) have limited exposure to the U.S. market despite some overreaction at first,” Kai Wang, Asia equity strategist at Morningstar, said in a statement Thursday. “We are expecting some fiscal policy intervention,” he said, “should there be incremental macro weakness.” China’s finance ministry indicated last month it was holding onto some dry powder given domestic and overseas uncertainties. Chinese policymakers are expected to hold a regular meeting later this month. Chinese tech stock valuations still look inexpensive relative to those in the U.S., Citi China equity strategist Pierre Lau and a team said in a report Thursday. They pointed out that average price-to-earnings ratio of seven leading tech-related Chinese stocks is 52% below that of U.S “Magnificent Seven” — not yet recovered to the historical average of 33% in the past five years. “We prefer domestic over export plays amid uncertainties stemming from higher tariffs,” the Citi strategists said. They also prefer services over goods sectors, and also like growth more than value. The firm is overweight on China internet, technology and transportation stock sectors. Citi’s top China stock buys include social media and gaming company Tencent , electric car giant BYD and home appliance company Haier , all listed in Hong Kong. Growing investor interest In a sign of how much investor interest has grown, nearly one-quarter of international investors have turned more positive on Chinese tech, the Citi strategists said, citing the firm’s U.S. marketing work last month. Global emerging markets equity funds’ allocation to China hit a 16-month high in late March , according to EPFR. Chinese startup DeepSeek released an AI model in late January that claimed to outperform OpenAI’s ChatGPT, despite U.S. restrictions on Chinese access to advanced chips for AI training. AI adoption is also expected to help Chinese companies cut costs , while policy aims to support consumer growth. Initial upgrades to Chinese companies’ earnings expectations are being driven by high-tech sectors and selected consumer companies, HSBC analysts pointed out Thursday. An index of 10 major Chinese tech companies traded in Hong Kong closed 1.2% lower Thursday, slightly better than the overall Hang Seng index’s 1.5% drop. The tech index remains more than 20% higher year to date, versus gains of just under 14% for the Hang Seng index. Another sector investment analysts say is relatively sheltered from the new tariffs is Chinese health care as pharmaceuticals were excluded from Trump’s latest round of tariffs. “Even if Trump imposed any tariffs in the future, most Chinese biotechs have U.S. partners and are not considered exporters, and tariffs on bulk drug makers could easily be transferred to downstream U.S. pharma,” Jefferies equity analyst Cui Cui and a team said in a note Wednesday. They also don’t expect reviving targeted legislation, such as the expired Biosecure Act , to become a U.S. priority soon. The Biosecure Act sought to restrict Chinese drug companies such as Wuxi Biologics from federal contracts. “Given that lowering drug prices in the U.S. is supported by both Republicans and Democrats, giving U.S. pharma companies the flexibility to operate efficiently and maintain an optimal cost structure is essential,” the Jefferies analysts said, highlighting expectations that Wuxi Biologics can operate at least twice as efficiently than competitors Samsung Bio and Lonza. Hong Kong-listed Wuxi Biologics said in late March that it expected ” accelerated and profitable growth in 2025 .” Jefferies rates the stock a buy. However, the extent of new U.S. tariffs and impact on China’s economy remains unclear. Morningstar’s Wang cautioned that tariffs would indirectly affect the tech sector given the likely negative impact on China’s gross domestic product, while market volatility may increase.